Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Nouveau Monde Graphite plans to raise capital via stock (SeekingAlpha) +++ NOUVEAU MONDE Aktie -4,89%

CORE LABORATORIES Aktie

>CORE LABS Performance
1 Woche: -4,9%
1 Monat: +3,1%
3 Monate: +27,4%
6 Monate: +29,8%
1 Jahr: -27,0%
laufendes Jahr: -15,6%
>CORE LABORATORIES Aktie
Name:  CORE LABORATORIES
Land:  USA
Sektor:  Energie
ISIN/ Wkn:  US21867A1051 / A3EB9S
Symbol/ Ticker:  HJ1 (Frankfurt) / CLB (NYSE)
Kürzel:  FRA:HJ1, ETR:HJ1, HJ1:GR, NYSE:CLB
Index:  -
Webseite:  https://www.corelab.com/
Profil:  Core Laboratories Inc. is a global leader in provi..
>Volltext..
Marktkapitalisierung:  638.22 Mio. EUR
Unternehmenswert:  763.96 Mio. EUR
Umsatz:  441.12 Mio. EUR
EBITDA:  50.59 Mio. EUR
Nettogewinn:  27.38 Mio. EUR
Gewinn je Aktie:  0.59 EUR
Schulden:  142.44 Mio. EUR
Liquide Mittel:  21.85 Mio. EUR
Operativer Cashflow:  42.52 Mio. EUR
Bargeldquote:  0.27
Umsatzwachstum:  -1.02%
Gewinnwachstum:  5.46%
Dividende je Aktie:  0.03 EUR
Dividendenrendite:  0.25%
Dividendenschätzung:  0.25%
Div. Historie:  03.11.25 - 0.008679€
04.08.25 - 0.008579999€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  CORE LABORATORIES, CORE LABS
Letzte Datenerhebung:  18.12.25
>CORE LABS Kennzahlen
Aktien/ Unternehmen:
Aktien: 46.56 Mio. St.
Frei handelbar: 98.92%
Rückkaufquote: 2.01%
Mitarbeiter: 3500
Umsatz/Mitarb.: 0.13 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -4.64%
Bewertung:
KGV: 23.69
KGV lG: 21.78
KUV: 1.51
KBV: 2.73
PEG-Ratio: 3.84
EV/EBITDA: 15.1
Rentabilität:
Bruttomarge: 17.12%
Gewinnmarge: 6.21%
Operative Marge: 8.64%
Managementeffizenz:
Gesamtkaprendite: 5.39%
Eigenkaprendite: 12.31%
>CORE LABS Peer Group

Es sind 157 Aktien bekannt.
 
03.12.25 - 16:00
Here′s Why Hold Strategy Is Apt for Core Laboratories Stock for Now (Zacks)
 
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties....
30.10.25 - 22:30
Trotz verfehlter Prognosen: Aktie von Core Laboratories legt nachbörslich kräftig zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.10.25 - 18:15
Core Laboratories Q3 Earnings Surpass Estimates, Decline Y/Y (Zacks)
 
CLB beats Q3 earnings estimates on strong Production Enhancement results. However, earnings dip y/y due to the Reservoir Description segment's weakness....
23.10.25 - 17:18
Core Laboratories projects Q4 2025 revenue of $132M–$136M as international demand drives growth (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 15:42
Earnings Call Transkript: Core Laboratories verfehlt Gewinnerwartungen für Q3 2025 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 23:09
Core Laboratories Non-GAAP EPS of $0.22 beats by $0.02, revenue of $134.52M beats by $3.22M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.25 - 23:36
Core Laboratories Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.10.25 - 19:00
Core Laboratories to Post Q3 Earnings: Key Metrics to Watch (Zacks)
 
CLB is set to post Q3 earnings amid volatile oil markets, with estimates hinting at lower revenues and profit declines....
15.10.25 - 17:30
Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
 
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
14.10.25 - 13:00
Strength Seen in Core Laboratories (CLB): Can Its 6.0% Jump Turn into More Strength? (Zacks)
 
Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....
06.10.25 - 16:45
Zacks Industry Outlook Highlights TechnipFMC, Archrock Inc and Core Laboratories (Zacks)
 
Despite lower oil prices and weak upstream spending, Zacks sees TechnipFMC, Archrock and Core Laboratories as resilient oilfield services plays....
06.10.25 - 16:00
Here′s Why Holding Core Laboratories Stock Is Justified for Now (Zacks)
 
CLB benefits from revenue expansion, proprietary tools & disciplined spending, though flat guidance, low dividends & sector competition remain headwinds....
30.09.25 - 22:18
CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC (PR Newswire)
 
HOUSTON, Sept. 30, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") announced today the acquisition of Brazil-based integrated geological services company, Solintec. For more than three decades, Solintec has provided integrated upstream oil and gas geological services to the vast......
29.09.25 - 16:00
Core Laboratories Stock Rebounds in a Month: Is it Time to Buy? (Zacks)
 
CLB stock rebounds with 13% gains in a month, outpacing peers and the energy sector as revenues, margins and cash flow strengthen....
24.09.25 - 22:33
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL (PR Newswire)
 
HOUSTON, Sept. 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on October 23, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate......
09.09.25 - 02:42
Maya and Duránd′s Superintelligence Human-Enhancement Technology Company, Labs, Raises $22.5 Million Series Seed Funding at a $10 Billion Valuation to Power its 7 Labs -- including Yuhmmy App, YuhmmyAI featuring Social-Taste AI Models (STAMs) a (PR Newswire)
 
Funding will drive development across Labs' 7 core Labs and support the fall launch of Yuhmmy App 2.0, the Social-Taste Super App reimagining digital craving, taste intelligence, and human-enhancements. SANTA MONICA, Calif., Sept. 8, 2025 /PRNewswire/ -- Labs Companies, Inc., the......
09.09.25 - 02:27
Maya and Duránd′s Superintelligence Human-Enhancement Technology Company, Labs, Raises $35 Million Series Seed II at a $12.5 Billion Valuation to Accelerate Yuhmmy App 2.0, YuhmmyAI and Yuhmmy AR/VR; Solely Led by JetDebt Finance (PR Newswire)
 
Funding will accelerate Yuhmmy App 2.0 first access at USC and UCLA this fall — turning mealtimes into live, on-camera connections — while expanding YuhmmyAI's Social-Taste Intelligence and advancing Labs' seven (7) core labs to build the Social-Taste Graph. SANTA MONICA, Calif., Sept. 8,......
03.08.25 - 21:39
XFRA: DIVIDEND/INTEREST INFORMATION - 04.08.2025 - US21867A1051 (XETRA)
 
Das Instrument HJ1 US21867A1051 CORE LABORATORIES EQUITY wird ex Dividende/Zinsen gehandelt am 04.08.2025 The instrument HJ1 US21867A1051 CORE LABORATORIES EQUITY has its ex-dividend/interest day on 04.08.2025...
28.07.25 - 21:12
Core Labs Posts Flat Revenue in Q2 (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer lesen kann, der ist niemals einsam. - Prof. Dr. Walter Jens
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!